SCHEMBL10612

SCHEMBL10612

c1ccc2c(c1)CNC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29351494 1.00 — —
SCHEMBL13590042 1.00 PNMT (0.65) —
Ammonia Solution, Strong SCHEMBL16296133 0.97 PNMT (0.62) —
SCHEMBL28633341 0.97 PNMT (0.62) —
Hydrochloric Acid SCHEMBL27941016 0.97 PNMT (0.62) —
Hydrochloric Acid SCHEMBL4702076 0.97 PNMT (0.62) —
SCHEMBL29361921 0.97 PNMT (0.62) —
Methane SCHEMBL11147358 0.97 PNMT (0.62) —
Hydrochloric Acid SCHEMBL29371527 0.97 PNMT (0.62) —
Methane SCHEMBL27536218 0.97 PNMT (0.62) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5063 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12435068-B2 Anthelmintic compounds ELANCO ANIMAL HEALTH GMBH (DE) 2025-10-07 — — US claimed
CN-115209883-B Novel cell metabolism regulating compound and use thereof 新月生物科学 2025-05-20 — — CN claimed
EP-4003524-B1 ISOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PARASITIC INFECTIONS ELANCO ANIMAL HEALTH GMBH (DE) 2025-04-09 — — EP claimed
US-20250092010-A1 DIHYDRO-2H-ISOINDOLE ESTER COMPOUND SHANGHAI MAIUS PHARMACEUTICAL CO. LTD. (CN) 2025-03-20 — — US claimed
EP-3634959-B1 QUINOLINE DERIVATIVES FOR TREATING INFECTIONS WITH HELMINTHS ELANCO ANIMAL HEALTH GMBH (DE) 2025-02-26 — — EP claimed
US-20240383893-A1 Hydroxamic Acid Compound Having ENPP1 Inhibitory Activity and Use Thereof HAIHE BIOPHARMA CO., LTD. (CN) 2024-11-21 — — US claimed
US-12071404-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2024-08-27 — — US claimed
EP-4400493-A1 HYDROXAMIC ACID COMPOUND HAVING ENPP1 INHIBITORY ACTIVITY AND USE THEREOF Haihe Biopharma Co., Ltd. (CN) 2024-07-17 — — EP claimed
EP-4385983-A1 DIHYDRO-2H-ISOINDOLE ESTER COMPOUND Shanghai Maius Pharmaceutical Co. Ltd. (CN) 2024-06-19 — — EP claimed
CN-117980293-A Hydroxamic acid compound with ENPP1 inhibitory activity and application thereof 上海海和药物研究开发股份有限公司 2024-05-03 — — CN claimed
EP-0566069-A1 Tachykinin receptor antagonists, isoquinolones and their production TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-10-20 — — EP claimed
EP-0529778-A1 Optically active isoindoline derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-03-03 — — EP claimed
EP-0525629-A2 5-membered heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-02-03 — — EP claimed
WO-1992014453-A1 COMPOSITIONS AND METHODS OF TREATMENT OF SYMPATHETICALLY MAINTAINED PAIN ARC 1, INC. (US) 1992-09-03 — — WO claimed
EP-0186187-B1 CEPHALOSPORIN DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1992-02-26 — — EP claimed
US-4960779-A Pyrrole derivatives, and pharmaceutical compositions which contain them and pharmacological methods of use RHONE-POULENC SANTE (FR) 1990-10-02 — — US claimed
US-4632918-A Novel β-lactam antibiotics BAYER AKTIENGESELLSCHAFT (DE) 1986-12-30 — — US claimed
EP-0056144-A1 Carboxylic acid derivatives, their preparation and use as pharmaceuticals Dr. Karl Thomae GmbH (DE) 1982-07-21 — — EP claimed
US-4165319-A Isoindoline pigments CIBA-GEIGY CORPORATION (US) 1979-08-21 — — US claimed
US-4105657-A PRODUCTION OF N-ALKYL DERIVATIVES OF CYCLIC ALKYLENIMINES BASF AKTIENGESELLSCHAFT (DE) 1978-08-08 — — US claimed
Send feedback